|
C20ORF177 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.145500E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.551440E-01 |
| Normal-vs-Stage2 |
4.176800E-01 |
| Normal-vs-Stage3 |
1.411940E-02 |
| Normal-vs-Stage4 |
2.524200E-02 |
| Stage1-vs-Stage2 |
6.960000E-01 |
| Stage1-vs-Stage3 |
1.464030E-01 |
| Stage1-vs-Stage4 |
1.846170E-01 |
| Stage2-vs-Stage3 |
1.676200E-01 |
| Stage2-vs-Stage4 |
1.892180E-01 |
| Stage3-vs-Stage4 |
8.888800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.910400E-02 |
| Normal-vs-AfricanAmerican |
8.637600E-01 |
| Normal-vs-Asian |
1.186160E-01 |
| Caucasian-vs-AfricanAmerican |
2.046800E-01 |
| Caucasian-vs-Asian |
9.825200E-01 |
| AfricanAmerican-vs-Asian |
2.716400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.903600E-03 |
| Normal-vs-Female |
1.462750E-01 |
| Male-vs-Female |
5.981600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.128800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.454200E-02 |
| Normal-vs-Age(61-80Yrs) |
7.600300E-02 |
| Normal-vs-Age(81-100Yrs) |
1.835020E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.917600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.675600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.703800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.751600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.016800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.529200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.614000E-02 |
| Classical-VS-Follicular |
8.763400E-01 |
| Classical-VS-Other |
2.313400E-01 |
| Classical-VS-Normal |
1.458240E-01 |
| Tall-VS-Follicular |
1.813350E-01 |
| Tall-VS-Other |
6.070800E-01 |
| Tall-VS-Normal |
1.361760E-02 |
| Follicular-VS-Other |
3.601600E-01 |
| Follicular-VS-Normal |
2.324000E-01 |
| Other-VS-Normal |
9.784000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.202820E-01 |
| Normal-vs-N1 |
5.995400E-03 |
| N0-vs-N1 |
6.934000E-02 |
|
|
